Clinical Trials Browser

Phase 1/2 × Not yet recruiting × Pancreatic Neoplasms × Clear all

NCT07539155 2026-04-20

Intratumoral MMR Vaccine Injection in Borderline Resectable/Unresectable Pancreatic Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07444541 2026-04-16

ANO31905 in Combination With Chemotherapy for CLDN18.2-Positive Locally Advanced Unresectable or Metastatic Pancreatic Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07529808 2026-04-15

ChefHat-001

Phase 1/2 Not yet recruiting

Gastrointestinal

Adenocarcinoma, Colonic Neoplasms, Gastrointestinal Neoplasms, Neoplasms, Pancreatic Neoplasms, Stomach Neoplasms

NCT07504263 2026-03-31

Phase 1/2a Study of RP-001 in Participants With Advanced Malignancies

Phase 1/2 Not yet recruiting

Gastrointestinal

Neoplasms, Pancreatic Neoplasms, Colorectal Neoplasms

NCT07477418 2026-03-17

PRISM-TAMP

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07377526 2026-01-30

Phase 1/2 Study TROP2 CAREngineered Cord Blood-Derived NK Cells + Belzutifan In Pancreatic Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07341737 2026-01-15

SL-28 for Advanced Solid Tumours

Phase 1/2 Not yet recruiting

BreastDermatologicGastrointestinalGenitourinaryGynecologicHead & NeckThoracic

Adenocarcinoma of Lung, Urinary Bladder Neoplasms, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Head and Neck Neoplasms, Intestinal Neoplasms, Kidney Neoplasms, Liver Neoplasms, Lung Neoplasms, Melanoma, Neoplasm Metastasis, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Endometrial Neoplasms

NCT07175389 2025-09-16

JDB153 Combined With Serplulimab for Pancreatic Cancer After Standard Treatment Failure

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT07153289 2025-09-03

ResCPa

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal

NCT06866977 2025-03-10

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT04381130 2025-02-26

A Phase I/IIa Study of EF-009 in Patients with Pancreatic Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06662669 2024-10-29

YL-13027 and/or HY-0102 Combined With AG Regimen Chemotherapy for Metastatic Pancreatic Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06513455 2024-07-22

Irinotecan Liposome，Albumin Paclitaxel and Gemcitabine First-line Treatment for Pancreatic Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06370754 2024-04-17

FD-IMPACT

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms

NCT06259058 2024-03-15

Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Neoplasms